Literature DB >> 6334029

Monocyte suppression of Fusobacterium nucleatum-induced human polyclonal B-lymphocyte activation.

D F Mangan, T Won, D E Lopatin.   

Abstract

Previous studies reported that Fusobacterium nucleatum induced polyclonal B-lymphocyte activation (PBA) as determined by immunoglobulin M production in cultures of human peripheral blood mononuclear cells. However, the PBA response was greatly enhanced when the cells were depleted of esterase-positive, adherent cells (i.e., monocytes). The purpose of this study was to confirm and further examine the suppression of F. nucleatum-induced PBA (F. nucleatum-PBA) by blood monocytes. For comparison, PBA induced by pokeweed mitogen (PWM-PBA), which is enhanced by monocytes, was assessed in some experiments. We found the removal of monocytes from unfractionated cells by (i) Sephadex G-10, (ii) anti-monocyte specific OM-1 monoclonal antibody plus complement, or (iii) L-leucine methyl ester, a compound which selectively kills lysosome-rich cells, resulted in a population of cells responsive to F. nucleatum-PBA and unresponsive to PWM-PBA. The addition of double adherence-purified monocytes (greater than 85% esterase-positive cells), particularly in concentrations of greater than 10%, to lymphocytes depleted of monocytes by G-10, OM-1, or L-leucine methyl ester treatments, suppressed F. nucleatum-PBA and enhanced PWM-PBA. Monocytes also suppressed a mixture of isolated T and B cells combined in a T/B cell ratio of 3:1, which is an optimal ratio for F. nucleatum-PBA. Allogeneic monocytes suppressed F. nucleatum-PBA, although at low numbers these cells were not as suppressive as autologous monocytes. Heating at 56 degrees C for 15 min, sonicating, or freeze-thawing the monocyte preparations resulted in an abrogation of monocyte-induced suppression of F. nucleatum-PBA. Kinetic studies in which fresh monocytes were added daily to lymphocytes stimulated with F. nucleatum or PWM showed that the monocytes must be added within the first 2 days of culture to suppress F. nucleatum-PBA or enhance PWM-PBA. Monocytes incubated with F. nucleatum for 48 h released into the culture medium a soluble factor that suppressed F. nucleatum-PBA. The results from this study demonstrate a potent mechanism by which the host might prevent exaggerated nonspecific immunoglobulin responses when exposed to PBA-inducing concentrations of F. nucleatum. On the other hand, the induction of suppressive monocytes (or monocyte-mediated suppressive factors) by interaction with F. nucleatum might result in the inhibition of host protective immune reactions.

Entities:  

Mesh:

Year:  1984        PMID: 6334029      PMCID: PMC261535          DOI: 10.1128/iai.46.2.332-339.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Primary in vitro antibody response of human peripheral blood lymphocytes: role of phagocytic mononuclear cells.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

2.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

4.  Suppressor adherent cells in human tuberculosis.

Authors:  J J Ellner
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

Review 5.  Participation of mononuclear phagocytes in chronic inflammatory diseases.

Authors:  R C Page; P Davies; A C Allison
Journal:  J Reticuloendothel Soc       Date:  1974-05

6.  Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease.

Authors:  B F Mackler; K B Frostad; P B Robertson; B M Levy
Journal:  J Periodontal Res       Date:  1977-01       Impact factor: 4.419

7.  Rapid identification of monocytes in a mixed mononuclear cell preparation.

Authors:  S B Tucker; R V Pierre; R E Jordon
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

8.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

9.  Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis.

Authors:  P Katz; A S Fauci
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

10.  Depletion of monocytes from human peripheral blood leucocytes by passage through sephadex G-10 columns.

Authors:  C M Alonso; R R Bernabé; E Moreno; F Diaz de Espada
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

View more
  5 in total

1.  Antibody synthesis specific for nonoral antigens in inflamed gingiva.

Authors:  S M Mallison; A K Szakal; R R Ranney; J G Tew
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Induction of apoptotic cell death in peripheral blood mononuclear and polymorphonuclear cells by an oral bacterium, Fusobacterium nucleatum.

Authors:  A Jewett; W R Hume; H Le; T N Huynh; Y W Han; G Cheng; W Shi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes.

Authors:  Christopher W Kaplan; Xiaoyuan Ma; Avina Paranjpe; Anahid Jewett; Renate Lux; Susan Kinder-Haake; Wenyuan Shi
Journal:  Infect Immun       Date:  2010-09-07       Impact factor: 3.441

Review 4.  Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.

Authors:  A I Bolstad; H B Jensen; V Bakken
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

5.  Low Abundance Fusobacterium Nucleatum Supports Early Pregnancy Development - An In Vitro Study.

Authors:  Martha Heusler; Rebekka Einenkel; Jens Ehrhardt; Damián Oscar Muzzio; Marek Zygmunt
Journal:  Front Immunol       Date:  2021-08-31       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.